Início › Doença Cardiovascular › Tennessee › Nashville
Ensaios clínicos de Doença Cardiovascular em Nashville, TN
18 estudos para Doença Cardiovascular estão buscando participantes em locais em Nashville e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecrutandoFase 4
- TriStar Centennial Medical Center, Nashville
ELEVATE-HFpEF Clinical Study
Recrutando
- Saint Thomas Research Institute, Nashville
Improving Veteran Referral to Cardiac Rehabilitation
Recrutando
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Product Surveillance Registry
RecrutandoEstudo observacional
- Nashville, Nashville
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recrutando
- Vanderbilt University Medical Center, Nashville
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecrutandoFase 3
- Vanderbilt Univ Medi Cen, Nashville
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Recrutando
- Vanderbilt University Medical Center, Nashville
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecrutandoFase 4Voluntários saudáveis bem-vindos
- Meharry Medical College, Nashville
- Nashville VA Medical Center, Nashville
- Vanderbilt University Medical Center, Nashville
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RecrutandoFase 2
- Vanderbilt University Medical Center, Nashville
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecrutandoFase 3
- Research Site, Nashville
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecrutandoFase 3
- Ascension Saint Thomas, Nashville
Global Paradise System US Post Approval Study
RecrutandoEstudo observacional
- Ascension Saint Thomas, Nashville
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Recrutando
- Vanderbilt, Nashville
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
RecrutandoFase 2
- Vanderbilt University Medical Center, Nashville
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recrutando
- Centennial Medical Center, Nashville
Randomized Trial of SGLT2i in Heart Transplant Recipients
RecrutandoFase 4
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Gut Microbiota in Metabolic Surgery
RecrutandoEstudo observacional
- Vanderbilt_University MC, Nashville
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Recrutando
- Centennial Medical Center, Nashville
Ensaios de Doença Cardiovascular em outras cidades
- Boston, MA37 estudos
- New York City, NY33 estudos
- Washington, DC28 estudos
- Houston, TX24 estudos
- Dallas, TX23 estudos
- Cleveland, OH22 estudos
- Atlanta, GA22 estudos
- Chicago, IL21 estudos
- Philadelphia, PA21 estudos
- Pittsburgh, PA20 estudos
- St. Louis, MO20 estudos
- Los Angeles, CA18 estudos
Outros estudos em Nashville
- Câncer de Pulmão de Não Pequenas Células97 estudos
- Câncer de Mama81 estudos
- Câncer Metastático70 estudos
- Câncer Colorretal69 estudos
- Câncer (todos os tipos)65 estudos
- Câncer de Ovário49 estudos
- Câncer de Próstata43 estudos
- Câncer de Pulmão40 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço39 estudos
- Câncer de Pâncreas39 estudos
- Câncer Endometrial38 estudos
- Melanoma33 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.